Active, not recruitingNCT05712161
DurAVR™ EFS
Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study
AI Description
To evaluate the safety and feasibility of DurAVR™ THV System in the treatment of subjects with symptomatic severe native aortic stenosis.
- Who can join
- older adult
- Participants
- 15
- Expected completion
- 2033-12
- Funded by
- industry
Conditions studied
Aortic Stenosis, Aortic Valve Calcification, Severe Aortic Valve Stenosis, Symptomatic Aortic Stenosis
What is being tested
- DEVICE: DurAVRTM THV System
What it measures
- All-cause mortality or disabling stroke, Mortality would be reported as rate of death/mortality at 30 days. Disabling stroke would be reported according to VARC-3 Guidelines, 30days
- Technical success, Freedom from mortality, successful device implant, and freedom from surgery or intervention related to the device., Immediate post procedure
Centers Participating
These centers are participating in this study. Reach out to them directly to learn more.
Registry entry updated 2026-06-26
Deciding whether to join a study is your choice, and you can ask a study team questions before you decide anything.
If you would rather we did it with you, call us on (656) 206-4686.